Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎ New York, NY
(646) 856-9261
info@rgenix.com
AACR Meeting

AACR Tumor Immunology and Immunotherapy Conference

AACR Tumor Immunology and Immunotherapy Conference

November 27 – 30, 2018  |  Loews Miami Beach Hotel, Miami Beach, Florida, USA

Wednesday, Nov. 28 – Plenary Session 3:

Metabolic Regulation in Tumors: Implications for Therapy
Session Chair: Matthew G. Vander Heiden, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts
3:30-6:00 p.m.

The LXR/ApoE pathway regulates the innate immune system in cancer

Masoud Tavazoie, Rgenix, Inc., New York, New York

 

Learn More